Anticuerpos monoclonales frente a BAMBI y uso para tratamiento de enfermedades inflamatorias

[EN] The present invention relates to a reverse two-hybrid method for the identification of missense-type mutations that prevent the binding of two interacting proteins. The invention also describes gene constructs that can be used in the method of the invention, as well as the host cell which comprises said constructs and can be used in the method of the invention.

[ES] Anticuerpos monoclonales frente a BAMBI y uso para tratamiento de enfermedades inflamatorias. La presente invención se refiere a anticuerpos monoclonales específicos frente a un péptido de la proteína BAMBI, así como a sus usos y métodos que los comprenden. Preferiblemente los anticuerpos se utilizan para el tratamiento de enfermedades autoinmunes.

Consejo Superior de Investigaciones Científicas (España), Universidad de Cantabria

B1 Patente sin examen previo

Peer reviewed

Country

Spain

Related Organizations

University of Cantabria
Spain

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average